IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

References

• Allen AM, Tishler RB. Commentary: IMRT for head and neck cancer: Many chapters left to write. Oncologist 2007; 12: 565–8
   PubMedGoogle Scholar
• Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46: 619
   PubMed Web of Science ®Google Scholar
• Fowler JF. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. Clin Oncol 2007; 19: 8
   PubMed Web of Science ®Google Scholar
• Fowler JF, Harari PM, Leborgne F, Leborgne JH. Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules. Radiother Oncol 2003; 69: 161
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362(9388)933–40
   PubMed Web of Science ®Google Scholar
• Madani I, Duthoy W, Derie C, De Gersem W, Boterberg T, Saerens M, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 68: 126–35
   PubMed Web of Science ®Google Scholar
• Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 2007; 85: 36–41
   PubMedGoogle Scholar
• Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, et al. Target volume definition for head and neck intensity modulated radiotherapy: Pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol 2007; 19: 604
   Google Scholar
• Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995; 32: 1227–37
   PubMed Web of Science ®Google Scholar
• Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567–78
   PubMed Web of Science ®Google Scholar
• Elting LS, Isitt J, Murphy BA, Garden AS, Gwede CK, Trotti A, et al. 2428: Retrospective and prospective studies of the severity of Oral Mucositis (OM) in Intensity Modulated Radiation Therapy (IMRT) compared to conventional radiation therapy in head and neck cancer (HNC) patients. Int J Radiat Oncol Biol Phys 2006; 66(3 Suppl 1)S447
   Google Scholar
• Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 67: 438–44
   PubMedGoogle Scholar
• Yao M, Chang K, Funk GF, Lu H, Tan H, Wacha J, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the University of Iowa experience. Int J Radiat Oncol Biol Phys 2007; 67: 1332–41
   PubMedGoogle Scholar
• Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233: 93–100
   PubMed Web of Science ®Google Scholar
• Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798–804
   PubMed Web of Science ®Google Scholar
• Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000; 18: 1458–64
   PubMed Web of Science ®Google Scholar
• Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004; 22: 4665–73
   PubMed Web of Science ®Google Scholar
• Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
   PubMed Web of Science ®Google Scholar
• Oita M, Ohmori K, Obinata K, Kinoshita R, Onimaru R, Tsuchiya K, et al. Uncertainty in treatment of head-and-neck tumors by use of intraoral mouthpiece and embedded fiducials. Int J Radiat Oncol Biol Phys 2006; 64: 1581–8
   PubMedGoogle Scholar
• http://www.rtog.org/members/protocols/0522/0522.pdf.
   Google Scholar
• Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004; 59: 242–9
   PubMed Web of Science ®Google Scholar
• Apisarnthanarax S, Elliott DD, El-Naggar AK, Asper JA, Blanco A, Ang KK, et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 2006; 64: 678–83
   PubMedGoogle Scholar
• Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol 2006; 24: 2618–23
   PubMed Web of Science ®Google Scholar
• Eisbruch A. Intensity-modulated radiation therapy in the treatment of head and neck cancer. Nat Clin Pract Oncol 2005; 2: 34–9
   PubMedGoogle Scholar
• Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma–the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005; 63: 410
   PubMedGoogle Scholar
• Hong TS, Tome WA, Chappell RJ, Harari PM. Variations in target delineation for head and neck IMRT: An international multi-institutional study. Int J Radiat Oncol Biol Phys 2004; 60: S157
   Web of Science ®Google Scholar
• Das IJ, Cheng CW, Chopra KL, Mitra RK, Srivastava SP, Glatstein E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008; 100: 300–7
   PubMedGoogle Scholar